KEGG   DRUG: Interferon alfa (NAMALWA)Help
Entry
D03305                      Drug                                   

Name
Interferon alfa (NAMALWA) (JP17);
Interferon alfa (BALL-1) (JAN);
Interferon alfa (INN);
OIF (TN)
Class
Antineoplastic
 DG01752  Interferone
Remark
Therapeutic category: 6399
ATC code: L03AB01
Chemical structure group: DG01750
Product (DG01750): D02745<US> D03305<JP>
Efficacy
Antineoplastic, Antiviral, Biological response modifier
Target
IFNAR1 [HSA:3454] [KO:K05130]
IFNAR2 [HSA:3455] [KO:K05131]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04620  Toll-like receptor signaling pathway
hsa04630  Jak-STAT signaling pathway
hsa04650  Natural killer cell mediated cytotoxicity
hsa05160  Hepatitis C
hsa05161  Hepatitis B
hsa05162  Measles
hsa05200  Pathways in cancer
Interaction
Drug interaction
Structure map
map07044  Antiviral agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L03 IMMUNOSTIMULANTS
   L03A IMMUNOSTIMULANTS
    L03AB Interferons
     L03AB01 Interferon alfa natural
      D03305  Interferon alfa (NAMALWA) (JP17) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   639  Miscellaneous
    6399  Others
     D03305  Interferon alfa (NAMALWA) (JP17); Interferon alfa (BALL-1) (JAN); Interferon alfa (INN)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Interferon receptors
    IFNAR1
     D03305  Interferon alfa (NAMALWA) (JP17) <JP>
    IFNAR2
     D03305  Interferon alfa (NAMALWA) (JP17) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D03305  Interferon alfa (NAMALWA)
  D03305  Interferon alfa (NAMALWA) injection
Antineoplastics [br08340.html]
 D03305
Antiinfectives [br08350.html]
 Antivirals
  D03305
BRITE hierarchy
Other DBs
CAS: 74899-72-2
PubChem: 17397456

» Japanese version   » Back

DBGET integrated database retrieval system